VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,922 | +78.7% | 1,372 | +100.0% | 0.00% | 0.0% |
| Q2 2023 | $20,656 | -27.8% | 686 | -22.4% | 0.00% | -50.0% |
| Q1 2023 | $28,598 | +12.9% | 884 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $25,335 | +20.6% | 884 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $21,000 | -12.5% | 884 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $24,000 | -54.7% | 884 | -36.1% | 0.00% | -50.0% |
| Q1 2022 | $53,000 | -17.2% | 1,384 | -30.7% | 0.00% | 0.0% |
| Q4 2021 | $64,000 | +12.3% | 1,998 | +4.2% | 0.00% | 0.0% |
| Q3 2021 | $57,000 | -33.7% | 1,918 | -23.8% | 0.00% | -42.9% |
| Q2 2021 | $86,000 | +7.5% | 2,518 | +2.4% | 0.01% | 0.0% |
| Q1 2021 | $80,000 | -10.1% | 2,458 | 0.0% | 0.01% | -12.5% |
| Q4 2020 | $89,000 | +21.9% | 2,458 | +32.3% | 0.01% | 0.0% |
| Q3 2020 | $73,000 | +942.9% | 1,858 | +838.4% | 0.01% | +700.0% |
| Q2 2020 | $7,000 | +40.0% | 198 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $5,000 | – | 198 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |